Advances in the treatment of small vessel vasculitis

Rheumatic Diseases Clinics of North America
E S Molloy, Carol A Langford

Abstract

The systemic small vessel vasculitides encompass Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome. The traditional approach to therapy, which incorporates cytotoxic drugs and glucocorticoids, is associated with a significant risk of relapse and treatment-related toxicity. The formation of multicenter collaborative groups has facilitated the execution of randomized controlled trials, and has led to the identification of several effective therapeutic options. This article reviews the existing data and refers to studies in progress that may answer some of the questions that remain regarding the treatment of the small vessel vasculitides.

References

Nov 1, 1992·Arthritis and Rheumatism·G S HoffmanA S Fauci
Mar 15, 1992·Annals of Internal Medicine·G S HoffmanA S Fauci
Aug 1, 1989·Postgraduate Medical Journal·H RodgersJ H Turney
May 1, 1986·Seminars in Arthritis and Rheumatism·P J Clements, J Davis
Jan 1, 1985·Mayo Clinic Proceedings·R A DeRemeeL H Weiland
Feb 1, 1994·Arthritis and Rheumatism·J C JennetteC G Kallenberg
Jan 1, 1993·Advances in Experimental Medicine and Biology·N B AllenR M McCallum
Jan 1, 1993·The Journal of Pediatrics·M RottemG S Hoffman
Jan 1, 1993·Current Opinion in Rheumatology·G S Hoffman
Mar 1, 1996·Annals of Internal Medicine·C Talar-WilliamsM C Sneller
Jan 1, 1996·QJM : Monthly Journal of the Association of Physicians·E Reinhold-KellerW L Gross
Aug 27, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M HaubitzR Brunkhorst
Sep 12, 1998·Annals of Internal Medicine·E TatsisW L Gross
May 6, 1999·The New England Journal of Medicine·D H PresentS J van Deventer
Jun 8, 1999·Lancet·G A BruynK J Korff
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Jun 30, 2000·QJM : Monthly Journal of the Association of Physicians·D R JayneC M Lockwood
Sep 27, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·K de GrootUNKNOWN EUVAS (European vasculitis study group)
Jan 5, 2002·Expert Opinion on Investigational Drugs·C Thomas-Golbanov, S Sridharan
Mar 20, 2002·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·O JónasdóttirK Bendtzen
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·Bernie ScallonCarrie Wagner
May 1, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Bart MaesYves Vanrenterghem
May 15, 2002·Annals of the Rheumatic Diseases·A D BoothD R Jayne
Jun 29, 2002·Journal of the American Society of Nephrology : JASN·Ronald J Falk, J Charles Jennette

❮ Previous
Next ❯

Citations

Aug 23, 2008·Rheumatology International·Bharath Manu Akkara Veetil, Barry M Schimmer
May 9, 2012·Pediatric Clinics of North America·Pamela F Weiss
May 12, 2012·Lancet·Carlo SalvaraniGene G Hunder
Jun 11, 2010·Best Practice & Research. Clinical Rheumatology·Rula A Hajj-Ali
Jul 11, 2008·Seminars in Arthritis and Rheumatism·Oscar-Danilo Ortega-HernandezJuan-Manuel Anaya
Feb 6, 2013·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Dehua GongZhihong Liu
Aug 26, 2009·The Journal of Allergy and Clinical Immunology·Rachel U Lee, Donald D Stevenson
Nov 8, 2013·The Neurohospitalist·Yana L KrisemanS Andrew Josephson
Apr 21, 2007·Current Treatment Options in Neurology·Eamonn S Molloy, Rula A Hajj-Ali
Dec 14, 2011·Current Opinion in Rheumatology·Carlo SalvaraniGene G Hunder
Dec 20, 2008·Current Opinion in Rheumatology·Rula A Hajj-Ali, Leonard H Calabrese
Jul 24, 2018·Therapeutic Advances in Neurological Disorders·Carolin BeukerJens Minnerup

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Rheumatology Reports
Carol A Langford
Current Treatment Options in Cardiovascular Medicine
Carol A Langford
Current Opinion in Rheumatology
Bernhard HellmichWolfgang L Gross
© 2021 Meta ULC. All rights reserved